FDA says finds 'unacceptable level' of carcinogen in Zantac and its generics

The U.S. Food and Drug Administration said on Wednesday it found "unacceptable levels" of a cancer-causing impurity in the popular heartburn drug Zantac and its generic versions known chemically as ranitidine.